Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
Phase 2
Completed
- Conditions
- Congestive Heart Failure
- First Posted Date
- 2009-08-12
- Last Posted Date
- 2014-05-15
- Lead Sponsor
- ELA Medical, Inc.
- Target Recruit Count
- 520
- Registration Number
- NCT00957541
- Locations
- 🇺🇸
Mountain Vista Hospital, Mesa, Arizona, United States
OVATIO CRT and SITUS OTW LV Lead Post Approval Study
Completed
- Conditions
- Heart Failure
- First Posted Date
- 2008-11-21
- Last Posted Date
- 2013-09-18
- Lead Sponsor
- ELA Medical, Inc.
- Target Recruit Count
- 2260
- Registration Number
- NCT00795873
- Locations
- 🇺🇸
Advanced Cardiac Specialists, Mesa, Arizona, United States
🇺🇸Southwest Cardiovascular Associates, Mesa, Arizona, United States
🇺🇸Cardiovascular Associates of Mesa, Mesa, Arizona, United States
Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study
Phase 3
Completed
- Conditions
- Sudden Cardiac Death
- First Posted Date
- 2008-01-04
- Last Posted Date
- 2012-03-02
- Lead Sponsor
- ELA Medical, Inc.
- Target Recruit Count
- 85
- Registration Number
- NCT00586378
- Locations
- 🇺🇸
Banner Baywood, Mesa, Arizona, United States
Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System
- Conditions
- Congestive Heart Failure (CHF)
- First Posted Date
- 2007-09-12
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- ELA Medical, Inc.
- Registration Number
- NCT00528320
News
No news found